期刊文献+

胃癌原发灶中上皮间质转化相关因子和CD133的表达及其与临床病理特征和预后的关系 被引量:3

Epithelial-Mesenchymal Transition Related Factors and CD133 Protein Expressions in Primary Lesion of Gastric Cancer and Its Relationship with Clinicopathologic Features and Prognosis
原文传递
导出
摘要 目的研究上皮间质转化(EMT)相关因子Snail、E-cadherin、N-cadherin与胃癌患者临床病理特征、预后及胃癌肿瘤起始细胞表面标志物CD133表达的关系。方法利用Western blot方法检测50例胃癌及癌旁正常胃黏膜组织中EMT相关因子及CD133蛋白的定位及定量表达,分析EMT相关因子及CD133蛋白表达与胃癌患者的临床病理学指标的关系,Spearman等级相关分析EMT相关因子和CD133表达的关系,Kaplan-Meier方法分析EMT相关因子及CD133表达与胃癌患者生存的关系。结果①胃癌组织中Snail、N-cadherin及CD133蛋白表达相对灰度值明显高于其在癌旁正常胃黏膜组织中的表达(Snail:0.599±0.114比0.259±0.108,P=0.020;N-cadherin:0.754±0.154比0.329±0.134,P=0.001;CD133:0.635±0.119比0.485±0.116,P=0.029),E-cadherin蛋白表达相对灰度值明显低于其在癌旁正常胃黏膜组织中的表达(0.378±0.123比0.752±0.156,P=0.003)。②Snail蛋白、N-cadherin蛋白表达平均相对灰度值在有血管浸润、淋巴管浸润、N3淋巴结转移及肿瘤直径≥5 cm和Ⅲ+Ⅳ期胃癌患者中的表达明显高于无血管浸润、淋巴管浸润、N0~N2淋巴结转移及肿瘤直径<5 cm和Ⅰ+Ⅱ期的胃癌患者(P<0.05),而E-cadherin蛋白表达平均相对灰度值在有血管浸润、淋巴管浸润、N3淋巴结转移及Ⅲ+Ⅳ期胃癌患者中的表达显著低于无血管浸润、淋巴管浸润、N0~N2淋巴结转移及Ⅰ+Ⅱ期的胃癌患者(P<0.05),CD133蛋白表达平均相对灰度值在有淋巴管浸润、N3淋巴结转移、肿瘤直径≥5 cm和Ⅲ+Ⅳ期胃癌患者中的表达显著高于无淋巴管浸润、N0~N2淋巴结转移、肿瘤直径<5 cm和Ⅰ+Ⅱ期的胃癌患者(P<0.05)。③Snail、N-cadherin蛋白表达与CD133蛋白表达分别均呈正相关(rs=0.278,P=0.048;rs=0.406,P=0.003),而E-cadherin蛋白表达与CD133蛋白表达呈负相关(rs=-0.504,P=0.000)。④Snail、N-cadherin及CD133蛋白低表达组的生存时间明显长于其高表达者(P<0.05),联合EMT相关因子和CD133蛋白表达能够最有效预测患者生存。结论EMT与胃癌肿瘤起始细胞特性之间存在明显相关,并且两者与胃癌的高侵袭的临床病理特征相关,联合EMT相关因子Snail、E-cadherin、N-cadherin与CD133能够最有效预测胃癌患者的预后。 Objective To investigate the prognostic value of epithelial-mesenchymal transition(EMT) related proteins(Snail,E-cadherin,and N-cadherin) in gastric cancer and its relationship with tumor initiating cells(TICs) marker(CD133).Methods The expressions of EMT-related proteins and CD133 protein in the gastric cancer tissues and normal gastric mucosa tissues adjacent to gastric cancer were detected by Western blot method.The relations between the expressions of EMT-related factors proteins and CD133 protein and the clinicopathologic characters were analyzed.The correlations between EMT-related factors and CD133 were analyzed by Spearman.The correlations between EMT-related factors expressions and CD133 expression and survival were analyzed by Kaplan-Meier method and Log-rank test.Results ① The protein expression levels of Snail,N-cadherin,and CD133 in the gastric cancer tissues were significantly higher than those in the normal gastric mucosa tissues adjacent to gastric cancer(Snail:0.599± 0.114 versus 0.259±0.108,P=0.020;N-cadherin:0.754±0.154 versus 0.329±0.134,P=0.001;CD133:0.635± 0.119 versus 0.485±0.116,P=0.029),while the protein expression level of E-cadherin was lower than that in the normal gastric mucosa tissues adjacent to gastric cancer(0.378±0.123 versus 0.752±0.156,P=0.003).② The expression levels of Snail and N-cadherin in the gastric cancer patients with vascular invasion,lymphatic vessel invasion,N3 lymph node metastasis,diameter more than 5 cm,and Ⅲ+Ⅳ staging were significantly higher than those in the patients without vascular invasion,lymphatic vessel invasion,N0-N2 lymph node metastasis,diameter less than 5 cm,andⅠ+Ⅱ staging(P〈0.05),while E-cadherin protein expression was lower than that in the patients without vascular invasion,lymphatic vessel invasion,N0?-?N2 lymph nodes metastasis,andⅠ+Ⅱstaging(P〈0.05).The expression levels of CD133 in the gastric cancer patients with lymphatic vessel invasion,diameter more than 5 cm,and Ⅲ+Ⅳ staging were significantly higher than those in the patients without lymphatic vessel invasion,diameter less than 5 cm,andⅠ+Ⅱ staging(P〈0.05).③The Snail and N-cadherin protein expressions were significantly positive correlated with CD133 protein expression,respectively(rs?=0.278,P=0.048;rs?=0.406,P=0.003),while E-cadherin protein expression was significantly negative correlated with CD133 protein expression(rs?=-0.504,P=0.000).④ The survival time in the patients with lower expressions of Snail,N-cadherin,and CD133 were significantly longer than those in the patients with higher expressions of Snail,N-cadherin,and CD133(P〈0.05).The combination of Snail,N-cadherin,E-cadherin,and CD133 could effectively predict survival.Conclusions There is a significant correlation between EMT and gastric cancer TICs,and which are correlated with aggressive clinicopathologic features of gastric cancer.The combination of Snail,E-cadherin,N-cadherin,and CD133 may be effectively predict the prognosis of gastric cancer patients.
出处 《中国普外基础与临床杂志》 CAS 2013年第5期492-498,共7页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金资助(项目编号:81101850) 上海市科委基金资助(项目编号:09411962300) 上海市卫生局基金资助(项目编号:2010018)~~
关键词 新生物 上皮间质转化 CD133 预后 Westernblot方法 Stomach Carcinoma/Neoplasma Epithelial-mesenchymal transition CD133 Prognosis Western blot method
  • 相关文献

参考文献17

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 2Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004 [J]. CACancer J Clin, 2004, 54(1): 8-29.
  • 3Thiery JP. Epithelial-mesenchymal transitions in tumour progres- sion [ J ]. Nat Rev Cancer, 2002, 2(6): 442-454.
  • 4Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease [J]. Cell, 2009, 139(5): 871-890.
  • 5Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells [J]. J Clin Oncol, 2008, 26(17): 2876-2882.
  • 6陆瑞祺,吴巨钢,周国才,姜海广,倪晓春,俞继卫,姜波健.胃癌CD133阳性细胞的纯化及其生物学特性研究[J].中国普外基础与临床杂志,2011,18(12):1265-1270. 被引量:10
  • 7Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence [J]. Gastric Cancer, 2007, 10(2): 75-83.
  • 8Wheelock M J, Johnson KR. Cadherins as modulators of cellular phenotype [J]. Annu Rev Cell Dev Biol, 2003, 19: 207-235.
  • 9Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis E J]. Science, 2011, 331(6024): 1559-1564.
  • 10Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it [J]. Dev Dyn,2005, 233(3): 706-720.

二级参考文献21

  • 1Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3(7):730-737.
  • 2Wulf GG,Wang RY,Kuehnle 1,et al.A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia[J].Blood,2001,98(4):1166-1173.
  • 3Pérez Castillo A,Aguilar-Morante D,Morales-García JA,et al.Cancer stem cells and brain tumors[J].Clin Transl Oncol,2008,10(5):262-267.
  • 4Field M,Alvarez A,Bushnev S,et al.Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients[J].Clin Neurosurg,2010,57:151-159.
  • 5Yu SC,Ping YF,Yi L,et al.Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87[J].Cancer Lett,2008,265(1):124-134.
  • 6Miraglia S,Godfrey W,Yin AH,et al.A novel five-transmembrane hematopoietic stem cell antigen:isolation,characterization,and molecular cloning[J].Blood,1997,90(12):5013-5021.
  • 7Kang MK,Kang SK.Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma[J].Stem Cells Dev,2007,16(5):837-847.
  • 8O'Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(7123):106-110.
  • 9Rappa G,Fodstad O,Lorico A.The stem cell-associated antigen CD133 (prominin-1) is a molecular therapeutic target for metastatic melanoma[J].Stem Cells,2008,26 (12):3008-3017.
  • 10Smith LM,Nesterova A,Ryan MC,et al.CD133/prominin1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers[J].Br J Cancer,2008,99(1):100-109.

共引文献9

同被引文献39

  • 1袁林,徐又先,沈世强,卢欣.血清E-钙黏连蛋白在肝细胞癌手术前后的表达及术后复发的意义[J].肿瘤防治研究,2014,41(2):153-156. 被引量:4
  • 2Esposito N N,Chivukula M,Dabbs D J,魏兵(摘译),步宏(审校).乳腺管状小叶癌E-cadherin/cate-nin的表达[J].临床与实验病理学杂志,2007,23(3):274-274. 被引量:8
  • 3徐江锋,罗庚求.上皮细胞间质转型与肿瘤转移[J].国际病理科学与临床杂志,2007,27(5):393-396. 被引量:17
  • 4Carette D, Perrard MH, Prisant N, et al. Hexavalent chromium at low concentration alters Sertoli cell barrier and connexin 43 gap junction but not claudin-ll and N-cadherin in the rat seminiferous tubule culture model [J]. Pharmacol, 2013, 268 ( 1 ) :27-36. DOI: 10.1016/j.taap.2013.01.016.
  • 5Baumgart E, Cohen MS, Silva Neto B, et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors [ J ]. Clin Cancer Res, 2007, 13 ( 6 ) : 1685-1694.
  • 6Zhang W, Feng M, Zheng G, et al. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition viaup-regulation of snail in MCF7 human breast cancer cells [ J]. Biochem Biophys Res Commun, 2012, 417 (2) : 679-685. DOI: 10.1016/j.bbrc. 2011.11.142.
  • 7Fuchs BC, Fujii T, Dorfman JD, et al. Epithlial-to-mesenchymal transition and integrin linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells [ J ]. Cancer Res, 2008, 68 ( 7 ) : 2391-2399. DOI: 10.1158/0008-5472. CAN-07-2460.
  • 8Buck E, Eyzaguirre A, Barr S, et al. Loss of homotypic cell adhesion by epithelial mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition [ J ]. Mol Cancer Ther, 2007, 6 ( 2 ) : 532-541.
  • 9Yaueh RL. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients [ J ]. Clin Cancer Res, 2005, 11 ( 24 ) : 8686-8698.
  • 10Xing X, Tang YB, Yuan G, et al. The prognostic value of E-cadherin in gastric cancer: a meta-analysis [ J ]. Int J Cancer, 2012, 132 ( 11 ) : 2589-2596. DOI: 10.1002/ijc.27947.

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部